AlenCiken

CFDA has granted priority review for EVOMELA

NASDAQ:CASI   CASI Pharmaceuticals, Inc.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.